L. Ko6a´cs et al. / Carbohydrate Research 337 (2002) 1171–1178
1177
4.50 (d, 1H, J1,2 8.9 Hz, H-1), 4.06 (dd, 1H, J4,5a 2.6 Hz,
J5,5b 13.2 Hz, H-5a), 3.67 (m, 1H, H-5b), 2.21, 2.07,
2.04 (s, 9H, acetyl CH3); 13C NMR (CDCl3): l 170.0,
169.7, 168.6 (acetyl CO), 109.6 (CN), 88.0 (C-1), 70.4,
67.5, 67.1 (C-2, C-3, C-4), 65.2 (C-5), 20.6, 20.3 (acetyl
CH3). Anal. Calcd for C23H30N2O14 (558.50): C, 49.46;
H, 5.41; N, 5.02. Found: C, 49.68; H, 5.55; N, 4.96.
H-1, H-6a, H-6a%), 4.20–4.05 (m, 2H, H-6b, H-6b%),
3.84 (m, 2H, H-5, H-5%), 3.61 (m, 1H, H-2), 3.55 (s, 3H,
OCH3), 2.11, 2.08, 2.04, 2.03 (s, 21H, acetyl CH3); 13C
NMR (CDCl3): l 184.6 (thiourea), 170.9, 170.6, 170.5,
169.7, 169.5 169.2 (acetyl CO), 101.9 (C-1), 82.9 (C-1%),
73.2, 72.7, 71.6, 70.5, 68.0, 67.8 (C-3, C-4, C-5, C-2%,
C-3%, C-4%, C-5%), 61.7, 61.5 (C-6, C-6%), 58.2 (C-2), 57.9
(OCH3), 20.5, 20.4 (acetyl CH3). Anal. Calcd for
C28H40N2O17S (708.70): C, 47.45; H, 5.69; N, 3.95.
Found: C, 47.52; H, 5.55; N, 3.89.
N,N-Bis(2,3,4-tri-O-acetyl-h-D-lyxopyranosyl)cyana-
mide (31).—Prepared from 20 (0.64 g, 2.00 mmol)
according to General Procedure B; Yield: 0.32 g (58%),
colourless crystalline product; mp 195–197 °C, [h]D
−51.5° (c 1.0, CHCl3); w (KBr): 2228 (N-CꢀN) and
Methyl 3,4,6-tri-O-acetyl-2-deoxy-2-(N%-methylcar-
bodiimido)-i- -glucopyranoside (36).—Compound 34
D
1
1752 (OAc) cm−1. H NMR (CDCl3): l 5.49 (t, 1H,
(1.99 g, 5.1 mmol) and 3.25 g (1.5 mmol) of HgO were
stirred in a mixture of 69 mL of CHCl3 and 69 mL of
water for 30 min at room temperature. The organic
layer was separated from the water, dried on CaCl2 and
filtrated. After evaporation of the solvent, the crude
product was purified by crystallisation (EtOAc–hex-
ane). Yield: 1.14 g (63%), colourless crystalline product,
mp 72–73 °C, [h]D +2.9° (c 1.0, CHCl3); w (KBr): 2148
J2,3 3.3 Hz, H-2), 5.35 (dd, 1H, J3,4 9.5 Hz, H-3), 4.82
(d, 1H, J1,2 3.3 Hz, H-1), 4.79 (dd, 1H, J4,5a 5.0 Hz,
J5a,5b 13.0 Hz, H-5a), 4.01 (dd, 1H, J4,5b 10.5 Hz, H-5b),
3.93 (m, 1H, H-4), 2.21, 2.16, 2.04 (s, 9H, acetyl CH3);
13C NMR (CDCl3): l 169.5, 168.8, 168.7 (acetyl CO),
110.7 (CN), 84.5 (C-1), 68.0, 67.4, 66.0 (C-2, C-3, C-4),
64.8 (C-5), 20.7, 20.5, 20.3 (acetyl CH3). Anal. Calcd
for C23H30N2O14 (558.50): C, 49.46; H, 5.41; N, 5.02.
Found: C, 49.52; H, 5.31; N, 5.15.
1
(NꢀCꢀN) and 1754 (OAc) cm−1. H NMR (CDCl3): l
4.97 (t, 1H, J3,4 9.5 Hz, H-3), 4.90 (t, 1H, J4,5 9.5 Hz,
H-4), 4.22 (dd, 1H, J5,6a 4.7 Hz, H-6a), 4.17 (d, 1H, J1,2
7.9 Hz, H-1), 4.04 (dd, 1H, J5,6b 1.6 Hz, J6,6b 12.1 Hz,
H-6b), 3.62 (ddd, 1H, H-5), 3.50 (s, 3H, OCH3), 3.36
(dd, 1H, J2,3 9.5 Hz, H-2), 2.88 (s, 3H, NCH3), 1.99,
1.93 (s, 9H, acetyl CH3); 13C NMR (CDCl3): l 170.4,
169.9, 169.4 (acetyl CO), 139.8 (NꢀCꢀN), 103.0 (C-1),
73.9, 71.5, 68.3 (C-3, C-4, C-5), 62.0 (C-6), 60.0 (C-2),
57.3 (OCH3), 32.1 (NCH3), 20.5, 20.4 (acetyl CH3).
Anal. Calcd for C15H22N2O8 (358.35): C, 50.28; H, 6.19;
N, 7.82. Found: C, 50.35; H, 6.05; N, 7.76.
Methyl
ioureido)-i-
O-acetyl-2-amino-2-deoxy-b-
3,4,6-tri-O-acetyl-2-deoxy-2-(N%-methylth-
-glucopyranoside (34).—Methyl 3,4,6-tri-
-glucopyranoside (32,
D
D
0.96 g, 3 mmol) and 0.22 g (3 mmol) of methylisothio-
cyanate were stirred at 80 °C in 6 mL EtOAc for 2 h.
After evaporation of the solvent, the crude product
(0.94 g) was purified by crystallisation (benzene–hex-
ane). Yield: 0.70 g (60%), mp 157–158 °C, colourless
crystalline product, [h]D +43.7° (c 1.0, CHCl3); w
(KBr): 3358, 1504, 1372 (thiourea) and 1748 (OAc)
cm−1. 1H NMR (CDCl3): l 6.86 (m, 1H, NH), 6.20 (m,
1H, NH), 5.15 (dd, 1H, J3,4 7.9 Hz, H-4), 5.11 (dd, 1H,
J2,3 9.0 Hz, H-3), 4.36 (d, 1H, J1,2 8.4 Hz, H-1), 4.31
(dd, 1H, J5,6a 4.7 Hz, J6a,6b 12.6 Hz, H-6a), 4.14 (dd,
1H, J5,6b 2.6 Hz, H-6b), 3.70 (ddd, 1H, J4,5 9.5 Hz,
H-5), 3.67 (m, 1H, H-2), 3.57 (s, 3H, OCH3), 3.07 (d,
3H, JNH,Me 3.3 Hz, NHMe), 2.10, 2.05 (s, 9H, acetyl
CH3); 13C NMR (CDCl3): l 180.8 (thiourea), 170.9,
170.4, 169.1 (acetyl CO), 104.6 (C-1), 75.0, 71.4, 67.9
(C-3, C-4, C-5), 61.9 (C-6), 58.6 (C-2), 57.0 (OCH3),
55.6 (NCH3), 20.5, 20.4 20.3 (acetyl CH3). Anal. Calcd
for C15H24N2O8S (392.43): C, 45.91; H, 6.16; N, 7.14.
Found: C, 46.34; H, 6.14; N: 6.81.
Methyl
tetra-O-acetyl-i-
3,4,6-tri-O-acetyl-2-deoxy-2-[N%-(2,3,4,6-
-glucopyranosyl)carbodiimido]-i-D-
D
glucopyranoside (37).—Prepared from 35 (1.42 g, 2.0
mmol) according to the previous procedure. Yield: 1.02
g (76%), colourless crystalline product, mp 141–142 °C,
[h]D +6.1° (c 1.0, CHCl3); w (KBr): 2148 (NꢀCꢀN) and
1
1750 (OAc) cm−1. H NMR (CDCl3): l 5.16 (Ct, 1H,
J4%,5% 8.5 Hz, H-4%), 5.10 (t, 1H, J4,5 9.5 Hz, H-4), 5.06
(dd, 1H, J3,4 9.5 Hz, H-3), 4.96 (t, 1H, J3%,4% 9.5 Hz,
H-3%), 4.91 (Ct, 1H, J2%,3% 9.5 Hz, H-2%), 4.69 (d, 1H, J1,2
8.9 Hz, H-1%), 4.32 (d, 1H, J1,2 8.4 Hz, H-1), 4.28 (dd,
1H, J5,6 4.5 Hz, J6a,6b 12.3 Hz, H-6a), 4.21 (dd, 1H,
J5%,6a% 2.1 Hz, J6a%,6b% 12.1 Hz, H-6a%), 4.16 (dd, 1H, J5%,6b%
4.5 Hz, H-6b%), 4.11 (dd, 1H, J5,6b 2.1 Hz, H-6b), 3.73
(ddd, 2H, H-5, H-5%), 3.57 (s, 3H, OCH3), 3.50 (dd, 1H,
J2,3 10.0 Hz, H-2), 2.09, 2.07, 2.06, 2.02, 2.00, 1.99 (s,
21H, acetyl CH3); 13C NMR (CDCl3): l 170.4, 169.9,
169.8, 169.4, 169.1 (acetyl CO), 137.6 (NꢀCꢀN), 102.4
(C-1), 84.2 (C-1%), 73.7, 71.5, 68.3 (C-3, C-4, C-5), 73.3,
72.7, 72.3, 67.8 (C-2%, C-3%, C-4%, C-5%), 61.7, 61.3 (C-6,
C-6%), 59.8 (C-2), 57.1 (OCH3), 20.5, 20.4 (acetyl CH3).
Anal. Calcd for C28H38N2O17 (674.62): C, 49.85; H,
5.68; N, 4.15. Found: C, 50.01; H, 5.52; N, 4.17.
Methyl
tetra-O-acetyl-i-
3,4,6-tri-O-acetyl-2-deoxy-2-[N%-(2,3,4,6-
-glucopyranosyl)thioureido]-i- -glu-
D
D
copyranoside (35).—Prepared from 32 (1.60 g, 5 mmol)
and 33 (1.94 g, 5 mmol) according to the previous
procedure. Yield: 2.96 g (84%), colourless crystalline
product, mp 191–192 °C (dry EtOH), [h]D +5.9° (c
1.0, CHCl3); w (KBr): 3372, 1562, 1366 (thiourea) and
1
1754 (OAc) cm−1. H NMR (CDCl3): l 6.53 (m, 1H,
NH), 5.81 (m, 1H, NH), 5.35 (dd, 1H, J3%,4% 8.9 Hz, J4%,5%
10.0 Hz, H-4%), 5.20–5.05 (m, 4H, H-3, H-4, H-2%,
H-3%), 5.01 (t, 1H, J1%,2% 9.5 Hz, H-1%), 4.45–4.25 (m, 3H,